CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Andrew Witty

Former Chief Executive Officer & Non-Independent Director, Unitedhealth

Search every verified Andrew Witty interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. On UnitedHealth Group’s fourth quarter 2024 earnings call, Andrew Witty addressed the company’s performance and strategic direction. He acknowledged a challenging 2024 marked by external funding reductions and described efforts to modernize the company, including a willingness to phase out parts of Optum Health’s business deemed less important to its future. Witty also reiterated a consistent approach to Medicare Advantage, stating that the company maintains targeted margins without significant pricing adjustments. Witty attributed higher U.S. healthcare costs primarily to higher prices for procedures, visits, and prescriptions rather than utilization rates. He also stated the company’s commitment to phasing out remaining rebate arrangements so that 100% of rebates go to customers by 2028, arguing this would clarify responsibility for drug pricing, which he placed on drug companies.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →